Skip to content
DefDex

Federal award

MEDPHARM INC.

HT941022P0004

Contract

Obligated and Ceiling

Obligated (net)
$671,040.94
Ceiling (potential value, not spending)
$871,761.72
Current value
$683,362.80
Gross positive obligations
$683,362.80

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
MEDPHARM INC. · DLM6VHZ3VUN3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
MEDPHARM INC. · DLM6VHZ3VUN3
Awarding agency
Department of War · sub-agency 97DH · office HT9410
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE
Industry (NAICS)
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PIID
HT941022P0004
Award type code
B
Actions
9 · Sep 7, 2022 to Apr 8, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History9

Award actions
DateFYModAction typeObligationCompany in company totals
Apr 8, 2026FY2026P00008B−$12,321.86
—
Dec 11, 2025FY2026P00007C$180,756.48
—
Jun 30, 2025FY2025P00006G$0.00
—
Nov 21, 2024FY2025P00005C$173,767.32
—
Sep 19, 2024FY2024P00004G$0.00
—
Oct 18, 2023FY2024P00003C$167,361.12
—
Sep 5, 2023FY2023P00002G$0.00
—
Oct 18, 2022FY2023P00001C$161,477.88
—
Sep 7, 2022FY20220—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.